CoChat

Re-detectable positive SARS-CoV-2 RNA tests in patients who recovered from COVID-19 with intestinal infection

Open access

The DOI matches its Crossref record; 16 of the 16 references it cites were found in a registry or an index.

Abstract

Dear Editor, Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), a novel coronavirus that causes Coronavirus Disease 2019 (COVID-19) (Yang and Wang, 2020), has spread to more than 200 countries and infected more than 9,000,000 people as of Jun 2020. Tens of thousands of patients with COVID-19 have recovered and been discharged from hospital. However, there are reports of recovered patients who subsequently tested positive for SARS-CoV-2 after discharge (re-detectable positive, RP) (An et al., 2020; Lan et al., 2020), and this has led to increasing focus on the mechanism(s) underlying RP. Several studies of discharged patients have been performed to investigate the proportion of RP and the clinical symptoms of these patients (An et al., 2020; Lan et al., 2020). One study revealed that four patients had positive SARS-CoV-2 RT-PCR tests 5 to 13 days after discharge (Lan et al., 2020), while a retrospective study in Wuhan, China reported that 8/108 (7.4%) patients were RP (Cao et al., 2020). Moreover, 14.5% of convalescent patients (n = 38) were RP for SARS-CoV-2 RNA in RT-PCR tests of both anal and nasopharyngeal swabs (An et al., 2020). RP is usually observed in young patients who had mild or moderate COVID-19 symptoms on the first admission, and several significant characteristic features including early RNA-negative conversion, fewer comorbidities, and more frequent upper respiratory symptoms (An et al., 2020). No obvious clinical symptoms were reported on the second admission of these patients (An et al., 2020; Lan et al., 2020; Cao et al., 2020). In recent reports, close contacts of RP patients were tested negative for SARS-CoV-2 RNA (An et al., 2020; Lan et al., 2020). However, as the patients were usually in quarantine after discharge, the infectivity of the patients might be underestimated. Two patients who were RP continued to be positive for SARS-COV-2 RNA for more than 90 days (Cao et al., 2020). Careful consideration should therefore be given to the potential for patients who are RP to become chronic virus-carriers. The cause of RP remains controversial, and consequently it is difficult to set standards for discharge and follow-up of patients. False negatives in qRT-PCR tests may partially explain the RP in some cases, because the lower limit of detection (LOD) of commercial RT-PCR kits is relatively high (An et al., 2020). The residual viremia could be another factor that leads to RP. Pathological examination of a ready-for-discharge patient who had COVID-19 identified viral particles in the pneumocytes. Several studies have reported the presence of SARS-CoV-2 RNA and viral particles in the gastrointestinal tracts of patients who had COVID-19, and that fecal samples remained viral RNA-positive after patients were respiratory-negative for SARS-CoV-2 and were discharged from hospital (Xu et al., 2020), thus highlighting the prolonged presence of SARS-CoV-2 in the gastrointestinal tract. Here, we investigated whether the intestine might be a “reservoir” of SARS-CoV-2 and one of the potential causes of RP. Between January 21 and March 8, 2020, a total of 173 patients who had COVID-19 were discharged from hospitals in Hefei, China, including the First Affiliated Hospital of University of Science and Technology of China (USTC). The patients were enrolled in this study for analysis of clinical parameters, and were followed for at least one month. During the monitoring, 12 out of 173 patients were found to be RP (Table S1). All 12 of these patients had gastrointestinal symptoms, including nausea, diarrhea, anorexia, abdominal pain and belching (Table S2), and three out of those patients who were RP developed a gastrointestinal symptom as the onset symptom (Table S2). In contrast to the reported 2%–39% of patients with COVID-19 who develop gastrointestinal symptoms (Chen et al., 2020; Zhang et al., 2020; Zheng et al., 2020), patients who were RP in Hefei had a much higher incidence of gastrointestinal symptoms (P-value < 2.2 × 10−16 by Chi-squared contingency table test). Patient G developed a fever and diarrhea over 3 days from January 28, 2020, was confirmed to have COVID-19 on February 4, and was then transferred to the intensive care unit (ICU) of the First Affiliated Hospital of USTC as a severe case. The patient experienced respiratory distress from February 4 to February 9. He was given glucocorticoid, immunoglobin, antibiotics, antiviral agents, tocilizumab (anti-IL6R), and probiotics, and supplied with oxygen. The respiratory distress symptoms significantly improved from February 11, and the patient was transferred out of the ICU on February 13. SARS-CoV-2 RNA tests on throat swab samples from the patient were negative on February 12 and 14, and he was discharged from hospital on February 20. After discharge, the patient remained in quarantine, and was tested for SARS-CoV-2 RNA every three days. A throat swab sample from the patient was again positive for SARS-CoV-2 RNA on March 5 (Fig.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1007/s13238-020-00778-8

Cites

16 of 16 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1 Longitudinal changes of COVID-19 specific immunoglobulins in patients during RP. (A) Throat swaps and fecal samples from COVID-19 RP patients were collected for RT-qPCR test. Days was count from the first day of confirmed SARS-CoV-2 RNA positive. The Black dot and triangle represents the time points of throat swap SARS-CoV-2 RNA positive and negative respectively. Red dot represents the time points of throat swap re-detectable SARS-CoV-2 RNA positive, and the green arrow represents the time points of fecal SARS-CoV-2 RNA positive. (B–H) Longitudinal changes of SARS-CoV-2 S protein-specific IgM, IgG and IgA in the serum of RP patients were quantified by ELISA. The red dots indicate time of RP
Figure 1 Longitudinal changes of COVID-19 specific immunoglobulins in patients during RP. (A) Throat swaps and fecal samples from COVID-19 RP patients were collected for RT-qPCR test. Days was count from the first day of confirmed SARS-CoV-2 RNA positive. The Black dot and triangle represents the time points of throat swap SARS-CoV-2 RNA positive and negative respectively. Red dot represents the time points of throat swap re-detectable SARS-CoV-2 RNA positive, and the green arrow represents the time points of fecal SARS-CoV-2 RNA positive. (B–H) Longitudinal changes of SARS-CoV-2 S protein-specific IgM, IgG and IgA in the serum of RP patients were quantified by ELISA. The red dots indicate time of RPCC BY · PubMed Central
Figure 2 Alternation of gut microbiota in RP patients. (A) SARS-CoV-2 S protein-specific IgA in Serum samples of RP and NRP patients were measured by ELISA (mean ± s.e.m., Student's t-test). Fecal DNA from RP and NRP patients were analyzed by 16s sequencing. (B) Alpha diversity was calculated by observed OTU number in RP or NRP patients (mean ± s.e.m., Student's t-test). PCA plot generated from (C) unweighted UniFrac distance matrix displayed the distinct clustering pattern of intestinal bacteria community in RP patients and NRP controls. (D and E) Composition differences were determined by linear discriminant analysis using LEfSe, and differential features were showed on taxonomic trees (D), or ranked by effect size (E)
Figure 2 Alternation of gut microbiota in RP patients. (A) SARS-CoV-2 S protein-specific IgA in Serum samples of RP and NRP patients were measured by ELISA (mean ± s.e.m., Student's t-test). Fecal DNA from RP and NRP patients were analyzed by 16s sequencing. (B) Alpha diversity was calculated by observed OTU number in RP or NRP patients (mean ± s.e.m., Student's t-test). PCA plot generated from (C) unweighted UniFrac distance matrix displayed the distinct clustering pattern of intestinal bacteria community in RP patients and NRP controls. (D and E) Composition differences were determined by linear discriminant analysis using LEfSe, and differential features were showed on taxonomic trees (D), or ranked by effect size (E)CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 16 references

Cited by

See all 42

Metadata

Authors
Tao, W., Wang, X., Zhang, G., Guo, M., Ma, H., Zhao, D., Sun, Y., He, J., Liu, L., Zhang, K., Wang, Y., Weng, J., Ma, X., Jin, T., & Zhu, S.
Affiliations
  • University of Science and Technology of China (CN)
  • Anhui Provincial Center for Disease Control and Prevention (CN)
Corresponding author
  • Ma, Xiaoling
  • Jin, Tengchuan
  • Zhu, Shu
Venue
Protein & Cell
Published
2020-09-26
Volume
12
Issue
3
Pages
230-235
ISSN
  • 1674-800X (ISSN-L)
  • 1674-8018
OpenAlex
W3088501530
Cited by
42
References
15
Citations by year
2025: 1 · 2023: 7 · 2022: 12 · 2021: 19 · 2020: 3
FWCI
1.34
Type
journal article
Language
en
Open access
Licence
Locations
  • Protein & Cell (publishedVersion, cc-by-nc)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Funders
  • National Natural Science Foundation of China (31770990, #81821001, 81822021, COVID-19, 91842105)
  • Chinese Academy of Sciences (XDB29030101)
  • University of Science and Technology of China
  • Fundamental Research Funds for the Central Universities (YD9110002001, WK2070000159)
Topics
  • Health Sciences › Medicine › Infectious Diseases › SARS-CoV-2 detection and testing
  • Health Sciences › Medicine › Infectious Diseases › COVID-19 Clinical Research Studies
  • Health Sciences › Medicine › Infectious Diseases › SARS-CoV-2 and COVID-19 Research
Keywords
SARS-CoV-2, COVID-19 pandemic, intestinal infection, gastrointestinal symptoms, RT-PCR, viral persistence, convalescent patients, anal swab, nasopharyngeal swab, quarantine, reinfection risk, close contacts, SARS-CoV-2 RNA
MeSH terms
COVID-19, SARS-CoV-2, Adult, Antibodies, Viral, Feces, Female, Humans, Intestines, Male, RNA, Ribosomal, 16S, RNA, Viral

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Re-detectable positive SARS-CoV-2 RNA tests in patients who recovered from COVID-19 with intestinal infection. https://app.cochat.ai/papers/10.1007/s13238-020-00778-8
The paper
Tao, W., Wang, X., Zhang, G., Guo, M., Ma, H., Zhao, D., Sun, Y., He, J., Liu, L., Zhang, K., Wang, Y., Weng, J., Ma, X., Jin, T., & Zhu, S. (2021). Re-detectable positive SARS-CoV-2 RNA tests in patients who recovered from COVID-19 with intestinal infection. Protein & Cell. https://doi.org/10.1007/s13238-020-00778-8

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.